TRDA - Entrada Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TRDA is currently covered by 3 analysts with an average price target of $13.45. This is a potential upside of $7.31 (119.06%) from yesterday's end of day stock price of $6.14.

Entrada Therapeutics's activity chart (see below) currently has 4 price targets and 18 ratings on display. The stock rating distribution of TRDA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.93% with an average time for these price targets to be met of 45.5 days.

Highest price target for TRDA is $28, Lowest price target is $20, average price target is $25.33.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 20-May-2025. First documented stock forecast 23-Nov-2021.

Best performing analysts who are covering TRDA - Entrada Therapeutics:

Raghuram Selvaraju Chris Shibutani Francois Brisebois Hartaj Singh

Currently out of the existing stock ratings of TRDA, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$20

$14.73 (279.51%)

$20

3 months 2 days ago
(20-May-2025)

5/14 (35.71%)

$11.76 (142.72%)

175

Buy

$28

$22.73 (431.31%)

$25

9 months 16 days ago
(06-Nov-2024)

0/2 (0%)

$9.34 (50.05%)

Buy

$28

$22.73 (431.31%)

$22

9 months 16 days ago
(06-Nov-2024)

0/2 (0%)

$9.34 (50.05%)

Hold

$18

$4.56 (33.93%)

$13

2 years 9 months 14 days ago
(08-Nov-2022)

3/3 (100%)

$-1.2 (-6.25%)

7

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TRDA (Entrada Therapeutics) average time for price targets to be met?

On average it took 45.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.93

Which analyst has the current highest performing score on TRDA (Entrada Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on TRDA (Entrada Therapeutics) with a proven track record?

HARTAJ SINGH

Which analyst has the most public recommendations on TRDA (Entrada Therapeutics)?

Raghuram Selvaraju has 22 price targets and 20 ratings on TRDA

Which analyst is the currently most bullish on TRDA (Entrada Therapeutics)?

Hartaj Singh with highest potential upside - $22.73

Which analyst is the currently most reserved on TRDA (Entrada Therapeutics)?

Chris Shibutani with lowest potential downside - $4.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?